Skip to content
Disclosery

FEDERATED HERMES, INC.: MLTX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of FEDERATED HERMES, INC. on MLTX, newest first. How the timeline and the estimate are built.

FEDERATED HERMES, INC. held 0 MLTX shares at 2025-09-30 per its 13F-HR filed 2025-11-03.

the latest 13F is the newest step

  1. period ended2025-09-30
    13F 0 shares
    Change vs previous 13F -1,248,573 shares

    13F-HR 0001623632-25-001496 filed by FEDERATED HERMES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-06-30
    13F 1,248,573 shares
    Change vs previous 13F -20,778 shares

    0.11% of the 13F portfolio, value $58,932,646.

    13F-HR 0001623632-25-000972 filed by FEDERATED HERMES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-03-31
    13F 1,269,351 shares
    Change vs previous 13F -10,701 shares

    0.11% of the 13F portfolio, value $49,593,543.

    13F-HR 0001623632-25-000548 filed by FEDERATED HERMES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-12-31
    13F 1,280,052 shares
    Change vs previous 13F +149,724 shares

    0.15% of the 13F portfolio, value $69,314,816.

    13F-HR 0001623632-25-000197 filed by FEDERATED HERMES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-09-30
    13F 1,130,328 shares
    Change vs previous 13F not available

    0.13% of the 13F portfolio, value $56,991,138.

    13F-HR 0001623632-24-001875 filed by FEDERATED HERMES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).